Cue Biopharma, Inc. · NASDAQ:CUE
Cue Biopharma, Inc. shareholders
As of Sep 30, 2026, 56 institutions reported holding Cue Biopharma, Inc., 56.0% of its shares. Largest: Ameriprise, Cormorant Asset Management, LP and Balyasny Asset Management L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cue Biopharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Ameriprise | 660K | 7.9% | new | Nov 16, 2026 |
| Cormorant Asset Management, LP | 625K | 7.5% | new | Nov 16, 2026 |
| Balyasny Asset Management L.P. | 427K | 5.1% | new | Nov 16, 2026 |
| Bleichroeder LP | 366K | 4.4% | −4,530 | Nov 13, 2026 |
| Vanguard | 354K | 4.2% | +166K | Nov 13, 2026 |
| Driehaus Capital Management LLC | 292K | 3.5% | no change | Nov 16, 2026 |
| Ikarian Capital, LLC | 291K | 3.5% | +186K | Nov 16, 2026 |
| Vivo Capital, LLC | 280K | 3.4% | new | Nov 13, 2026 |
| Morgan Stanley | 204K | 2.4% | +203K | Nov 13, 2026 |
| Adage Capital Partners Gp, L.L.C. | 200K | 2.4% | new | Nov 16, 2026 |